News Releases

Keyword Search
 
2014 | 2013 | 2012 | 2011 | 2010
DateTitle 
08/13/14Gevo Reports Second Quarter 2014 Financial Results
Luverne plant commences Side-by-Side production Reports EPS of ($0.25) Ended the second quarter with cash and cash equivalents of $5.9 million Luverne plant producing both isobutanol and ethanol in Side-by-Side operational mode (SBS) Closed an $18 million public offering of common stock and warrants Shipped renewable para-xylene to Toray Industries, Inc. (Toray) ENGLEWOOD, Colo., Aug. 13, 2014 (GLOBE NEWSWIRE) -- Gevo, Inc. (Nasdaq:GEVO) today announced its ... 
Printer Friendly Version
08/04/14Gevo to Host Conference Call to Report Second Quarter Financial Results on August 13, 2014
ENGLEWOOD, Colo., Aug. 4, 2014 (GLOBE NEWSWIRE) -- Gevo, Inc. (Nasdaq:GEVO) today announced that the company will host a conference call on Wednesday, August 13, 2014 at 4:30 p.m. EDT (2:30 p.m. MDT) to report its financial results for the first quarter ended June 30, 2014 and provide an update on recent corporate highlights. To participate in the conference call, please dial 1(800) 708-4540 (inside the U.S.) or 1 (847) 619-6397 (outside the U.S.) and reference the access code 37684059. The ... 
Printer Friendly Version
07/31/14Gevo Announces Pricing of Public Offering of Common Stock and Warrants
ENGLEWOOD, Colo., July 31, 2014 (GLOBE NEWSWIRE) -- Gevo, Inc. (Nasdaq:GEVO), a leading renewable chemicals and next-generation biofuels company, announced today that it has priced its underwritten public offering of common stock units. Gevo announced that it has agreed to sell 30,000,000 common stock units. Each common stock unit consists of one share of common stock and a warrant to purchase 0.5 shares of common stock, at a public offering price of $0.60 per common stock unit. Each warrant... 
Printer Friendly Version
07/30/14Gevo Announces Proposed Public Offering of Common Stock and Warrants
ENGLEWOOD, Colo., July 30, 2014 (GLOBE NEWSWIRE) -- Gevo, Inc. (Nasdaq:GEVO), a leading renewable chemicals and next-generation biofuels company, announced today that it intends to offer and sell, subject to market and other conditions, common stock units. Each common stock unit will consist of one share of common stock and a warrant to purchase a certain number of shares of common stock. The units are to be sold by Gevo subject to market and other conditions in an underwritten public offering. ... 
Printer Friendly Version
07/28/14Side-by-Side Operation of Luverne Plant on Track
Gevo Producing Both Isobutanol and Ethanol ENGLEWOOD, Colo., July 28, 2014 (GLOBE NEWSWIRE) -- Gevo, Inc. (Nasdaq:GEVO) today reported an update on the progress of the implementation of the Side-by-Side operational mode (SBS) of its plant in Luverne, MN. In the beginning of June, Gevo commenced the co-production of isobutanol and ethanol, with one fermenter dedicated to isobutanol production and three fermenters dedicated to ethanol production. This follows the company's announcement in May tha... 
Printer Friendly Version
05/29/14Gevo Ships Renewable Para-Xylene to Toray
Toray to Convert Gevo's Para-Xylene to Bio-Polyester (PET) ENGLEWOOD, Colo., May 29, 2014 (GLOBE NEWSWIRE) -- Gevo, Inc. (Nasdaq:GEVO) announced that it is selling para-xylene (PX) derived from its renewable isobutanol to Toray, one of the world's leading producers of fibers, plastics, films, and chemicals. PX is a primary raw material for the manufacture of bio-polyester (PET). PET has the largest global market share of all synthetic fibers and is also used in plastic bottles, films, and as a ... 
Printer Friendly Version
05/14/14Gevo Reports First Quarter 2014 Financial Results
Luverne plant commences Side-by-Side production Reports EPS of ($0.18) Ended the first quarter with cash and cash equivalents of $8.4 million Luverne plant commenced Side-by-Side production Closed a $25.9 million financing with Whitebox Advisors Lufthansa testing Gevo's bio-jet fuel ENGLEWOOD, Colo., May 14, 2014 (GLOBE NEWSWIRE) -- Gevo, Inc. (Nasdaq:GEVO) today announced its financial results for the three months ended March 31, 2014 and provided an update... 
Printer Friendly Version
05/09/14Gevo, Inc. Announces Closing of $25.9 Million Financing With Whitebox Advisors LLC
ENGLEWOOD, Colo., May 9, 2014 (GLOBE NEWSWIRE) -- Gevo, Inc. (Nasdaq:GEVO), a leading renewable technology, chemical products, and next generation biofuels company, announced the closing of a private debt financing (Financing) with Whitebox Advisors LLC (Whitebox) consisting of a senior secured term loan (Term Loan) exchangeable into senior secured convertible debentures (Convertible Debentures). The aggregate proceeds from the Term Loan are $25.9 million with an option for Gevo to draw an a... 
Printer Friendly Version
04/22/14Lufthansa to Evaluate Gevo's Renewable Jet Fuel
Lufthansa's Testing Supported by the European Commission ENGLEWOOD, Colo., April 22, 2014 (GLOBE NEWSWIRE) -- Gevo, Inc. (Nasdaq:GEVO), the world's only commercial producer of renewable isobutanol, announced today that it has come to an agreement with Lufthansa to evaluate Gevo's renewable jet fuel with the goal of approving Gevo's alcohol-to-jet fuel (ATJ) for commercial aviation use. Lufthansa's testing is being supported through work with the European Commission. "ATJ, like the Fischer-T... 
Printer Friendly Version
04/21/14Gevo to Host Conference Call to Report First Quarter Financial Results on May 14, 2014
ENGLEWOOD, Colo., April 21, 2014 (GLOBE NEWSWIRE) -- Gevo, Inc. (Nasdaq:GEVO) today announced that the company will host a conference call on Wednesday, May 14, 2014 at 4:30 p.m. EDT (2:30 p.m. MDT) to report its financial results for the first quarter ended March 31, 2014 and provide an update on recent corporate highlights. To participate in the conference call, please dial 1(800) 708-4540 (inside the U.S.) or 1 (847) 619-6397 (outside the U.S.) and reference the access code 37075054. The ... 
Printer Friendly Version
03/25/14Gevo Reports Fourth Quarter 2013 Financial Results
Optimizing utilization and cash flows of Luverne plant by producing both isobutanol and ethanol Reports EPS of ($0.35) Ended the fourth quarter with cash and cash equivalents of $24.6 million Transitioning Luverne plant to the production of both isobutanol and ethanol Produced isobutanol from mash using our yeast biocatalyst and GIFT® Signed licensing LOI with Porta Hnos S.A. to become exclusive licensee in Argentina Began selling bio-isooctane for high perf... 
Printer Friendly Version
03/06/14Porta Hnos S.A. Signs Agreement to Become Exclusive Licensee of Gevo's GIFT(R) Technology in Argentina
ENGLEWOOD, Colo., March 6, 2014 (GLOBE NEWSWIRE) -- Gevo, Inc. (Nasdaq:GEVO), the world's only commercial producer of renewable isobutanol, announced today that Porta Hnos S.A. ("Porta") has signed a letter of intent to become the exclusive licensee of GIFT® in Argentina to produce renewable isobutanol. "Isobutanol's versatility and hydrocarbon-like properties make it an ideal renewable fuel and chemical for Argentina and Gevo's GIFT® technology is the most efficient way to produce it," said... 
Printer Friendly Version
03/04/14Gevo to Host Conference Call to Report Fourth Quarter Financial Results on March 25, 2014
ENGLEWOOD, Colo., March 4, 2014 (GLOBE NEWSWIRE) -- Gevo, Inc. (Nasdaq:GEVO) today announced that the company will host a conference call on Tuesday, March 25, 2014 at 4:30 p.m. EDT (2:30 p.m. MDT) to report its financial results for the fourth quarter ended December 31, 2013 and provide an update on recent corporate highlights. To participate in the conference call, please dial 1 (800) 708-4540 (inside the US) or 1 (847) 619-6397 (outside the US) and reference the access code 36623383. The ... 
Printer Friendly Version
02/18/14Appeals Court Issues Opinion Sending Case Back to District Court
Court Orders District Court Proceedings Considering Revised Claim Interpretation ENGLEWOOD, Colo., Feb. 18, 2014 (GLOBE NEWSWIRE) -- Gevo, Inc. (Nasdaq:GEVO), the world's only commercial producer of renewable isobutanol, announced today that the U.S. Court of Appeals for the Federal Circuit (Appeals Court) issued a decision in a patent case involving Butamax's Patent Nos. 7,851,188 ('188 Patent) and 7,993,889 ('889 Patent). The appeals court offered a new interpretation of a disputed claim term... 
Printer Friendly Version